Fri, Jun 20, 2025 | Updated 03:26 IST
Bharat Biotech confirms deal with Brazil to supply 20 million doses of Covaxin vaccine
Feb 26, 2021
New Delhi [India], February 26 : Bharat Biotech International Limited on Friday confirmed that the company has signed an agreement with Brazil for the...
Ecuador envoy takes part in Covaxin trials, says Indian vaccines safe, convenient
Jan 08, 2021
New Delhi [India], January 8 : After taking the first shot of Covaxin, Ecuador's Envoy to India Hector Cueva Jacome on Friday said that...
WHO panel to decide on Covaxin EUL tomorrow
Nov 02, 2021
New Delhi [India], November 2 : The Technical Advisory Group (TAG), an independent advisory panel of the World Health Organisation (WHO), has sought additional...
IVI, Bharat Biotech announce start of global Phase II/III clinical trial of Chikungunya vaccine
Aug 25, 2021
Hyderabad (Telangana) [India], August 25 : The International Vaccine Institute (IVI) and Bharat Biotech on Wednesday announced the beginning of Phase II/III clinical trial...
IIL partners with Bharat Biotech to produce drug substance for Covaxin from mid-June
May 28, 2021
Hyderabad (Telangana) [India], May 28 : Indian Immunologicals Limited (IIL) has partnered with Hyderabad-based Bharat Biotech to manufacture drug substance for 'Covaxin' to ramp...
COVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin phase-3 clinical trials
Jan 07, 2021
Hyderabad (Telangana) [India], January 7 : The Bharat Biotech International Limited on Thursday announced the successful completion of volunteer enrolment for phase-3 clinical trials...
Vice President discusses status of indigenous vaccine against COVID-19
Dec 25, 2020
Delhi-based Dr. Dang's lab partners with Bharat Biotech for human clinical trials of Covaxin
Jul 22, 2020
Covaxin to be available in the first quarter of next year, says Bharat Biotech
Dec 09, 2020
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID booster intranasal vaccine
Jan 05, 2022
Paediatric trials of Covaxin may begin in June
May 23, 2021
Phase 3 clinical trials of Covaxin shows 81 per cent efficacy, says Bharat Biotech
Mar 03, 2021
Related Videos
No Result Found